CODX
Co-Diagnostics, Inc. Common StockNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$18.54M
P/E Ratio
—
EPS
$-32.26
Beta
1.26
52W High
$46.50
52W Low
$1.26
50-Day MA
$1.90
200-Day MA
$6.62
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
15.36
PEG Ratio
0.00
About Co-Diagnostics, Inc. Common Stock
Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.
Fundamentals
| Revenue (TTM) | 718,170 |
| Gross Profit (TTM) | 323,610 |
| EBITDA | $-30.84M |
| Operating Margin | -6309.00% |
| Return on Equity | -151.70% |
| Return on Assets | -52.10% |
| Revenue/Share (TTM) | $0.44 |
| Book Value | $4.45 |
| Price-to-Book | 1.16 |
| Price-to-Sales (TTM) | 25.82 |
| EV/Revenue | 17.29 |
| EV/EBITDA | 0.52 |
| Quarterly Earnings Growth (YoY) | 30.80% |
| Quarterly Revenue Growth (YoY) | 190.30% |
| Shares Outstanding | $3.66M |
| Float | $3.50M |
| % Insiders | 3.29% |
| % Institutions | 1.39% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026